Bmal1 and Gut-lung axis in SARS-CoV-2 infection: New insight into the effects of melatonin on COVID-19 patients?

Biomed Pharmacother. 2023 Aug:164:114291. doi: 10.1016/j.biopha.2023.114291. Epub 2023 Jan 23.

Abstract

Coronavirus disease 2019 (COVID-19), is known as one of the most known challenge worldwide. Numerous studies have tried to introduce different mechanisms involved in the pathophysiology of COVID-19 and efforts in this field are also ongoing. The presence of SARS-CoV-2 RNA in feces of COVID-19 patients along with a variety of gastrointestinal symptoms may show a significant association between gut microbiota and SARS-CoV-2 infection. However, the exact mechanism indicating how SARS-CoV-2 and gut flora influence each other remains unknown. This paper aims to introduce a possible molecular mechanism based on recent findings on the association between circadian rhythm and gut flora in COVID-19 patients to express a new insight into the probable mechanism of melatonin in protection against SARS-CoV-2 infection.

Keywords: Bmal1; Gut microbiota; Melatonin; SARS-CoV-2.

MeSH terms

  • COVID-19*
  • Gastrointestinal Tract
  • Humans
  • Lung
  • Melatonin* / metabolism
  • Melatonin* / pharmacology
  • Melatonin* / therapeutic use
  • RNA, Viral
  • SARS-CoV-2

Substances

  • Melatonin
  • RNA, Viral
  • BMAL1 protein, human